Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enlivex Ltd. - Ordinary Shares
(NQ:
ENLV
)
0.9595
-0.0212 (-2.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
255,987
Open
1.000
Bid (Size)
0.9404 (100)
Ask (Size)
1.080 (1,000)
Prev. Close
0.9807
Today's Range
0.9500 - 1.070
52wk Range
0.9500 - 27.15
Shares Outstanding
18,306,186
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June
July 30, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones
July 29, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Performance
YTD
-91.5%
-91.5%
1 Month
-43.2%
-43.2%
3 Month
-90.3%
-90.3%
6 Month
-94.1%
-94.1%
1 Year
-94.0%
-94.0%
More News
Read More
These stocks are moving in today's session
↗
July 28, 2026
Via
Chartmill
Top stock movements in today's session.
↗
July 28, 2026
Via
Chartmill
Which stocks are gapping on Tuesday?
↗
July 28, 2026
Via
Chartmill
Which stocks are moving before the opening bell on Tuesday?
↗
July 28, 2026
Via
Chartmill
Enlivex Announces $400,000,000 Private Placement
July 28, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
What's going on in today's pre-market session
↗
July 20, 2026
Via
Chartmill
Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion
July 20, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
July 13, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026
July 07, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume
June 24, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion
June 22, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
June 15, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026
June 02, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026
June 01, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board
May 28, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
May 27, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification
May 15, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange
April 30, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million
April 28, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
April 23, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
April 21, 2026
From
Enlivex Ltd.
Via
GlobeNewswire
Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025
March 26, 2026
Via
NewMediaWire
Frequently Asked Questions
Is Enlivex Ltd. - Ordinary Shares publicly traded?
Yes, Enlivex Ltd. - Ordinary Shares is publicly traded.
What exchange does Enlivex Ltd. - Ordinary Shares trade on?
Enlivex Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Enlivex Ltd. - Ordinary Shares?
The ticker symbol for Enlivex Ltd. - Ordinary Shares is ENLV on the Nasdaq Stock Market
What is the current price of Enlivex Ltd. - Ordinary Shares?
The current price of Enlivex Ltd. - Ordinary Shares is 0.9595
When was Enlivex Ltd. - Ordinary Shares last traded?
The last trade of Enlivex Ltd. - Ordinary Shares was at 09/11/26 04:00 PM ET
What is the market capitalization of Enlivex Ltd. - Ordinary Shares?
The market capitalization of Enlivex Ltd. - Ordinary Shares is 17.56M
How many shares of Enlivex Ltd. - Ordinary Shares are outstanding?
Enlivex Ltd. - Ordinary Shares has 18M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
